289 related articles for article (PubMed ID: 27667501)
1. Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.
Gauthier TP; Moreira E; Chan C; Cabrera A; Toro M; Carrasquillo MZ; Corentin M; Sherman EM
J Am Pharm Assoc (2003); 2016; 56(6):670-676. PubMed ID: 27667501
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist-driven multidisciplinary pretreatment workup process for hepatitis C care: A novel model for same-day pretreatment workup.
Houck KK; Ifeachor AP; Fleming BS; Andres AM; O'Donovan KN; Johnson AJ; Liangpunsakul S
J Am Pharm Assoc (2003); 2019; 59(5):710-716. PubMed ID: 31227418
[TBL] [Abstract][Full Text] [Related]
3. A population approach to disease management: hepatitis C direct-acting antiviral use in a large health care system.
Belperio PS; Backus LI; Ross D; Neuhauser MM; Mole LA
J Manag Care Spec Pharm; 2014 Jun; 20(6):533-40. PubMed ID: 24856591
[TBL] [Abstract][Full Text] [Related]
4. Treatment of patients with HIV or hepatitis C by pharmacist clinicians in a patient-centered medical home.
Ryan KL; Jakeman B; Conklin J; Pineda LJ; Deming P; Mercier RC
Am J Health Syst Pharm; 2019 May; 76(11):821-828. PubMed ID: 31053839
[TBL] [Abstract][Full Text] [Related]
5. Influence of Successful Chronic Hepatitis C Virus Treatment with Ledipasvir/Sofosbuvir on Warfarin Dosing Requirements in Four Veterans.
Britnell SR; Willets AE; Vanderman AJ; Woodard CL; Britt RB
Pharmacotherapy; 2016 Nov; 36(11):1173-1179. PubMed ID: 27716978
[TBL] [Abstract][Full Text] [Related]
6. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
7. Integration and compensation of pharmacists into primary care medical groups.
Woodhouse A; Clements E; Keedy C; Presnell A; Schnibben A
J Am Pharm Assoc (2003); 2019; 59(6):886-890. PubMed ID: 31521587
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a pharmacist-managed hepatitis C care clinic.
Smith JP; Dong MH; Kaunitz JD
Am J Health Syst Pharm; 2007 Mar; 64(6):632-6. PubMed ID: 17353572
[TBL] [Abstract][Full Text] [Related]
9. Pharmacist-initiated hepatitis C virus screening in a community pharmacy to increase awareness and link to care at the medical center.
Isho NY; Kachlic MD; Marcelo JC; Martin MT
J Am Pharm Assoc (2003); 2017; 57(3S):S259-S264. PubMed ID: 28506379
[TBL] [Abstract][Full Text] [Related]
10. Pharmacist's role in a Parkinson's disease and movement disorders clinic.
Poon LH; Lee AJ; Chiao TB; Kang GA; Heath S; Glass GA
Am J Health Syst Pharm; 2012 Mar; 69(6):518-20. PubMed ID: 22382484
[TBL] [Abstract][Full Text] [Related]
11. Integration of pharmacists into a patient-centered medical home.
Scott MA; Hitch B; Ray L; Colvin G
J Am Pharm Assoc (2003); 2011; 51(2):161-6. PubMed ID: 21382805
[TBL] [Abstract][Full Text] [Related]
12. A Regional Analysis of Hepatitis C Virus Collaborative Care With Pharmacists in Indian Health Service Facilities.
Geiger R; Steinert J; McElwee G; Carver J; Montanez R; Niewoehner J; Clark C; Reilley B
J Prim Care Community Health; 2018; 9():2150132718807520. PubMed ID: 30348039
[TBL] [Abstract][Full Text] [Related]
13. Assessing the proportion of patients with hepatitis C treated before and after initiation of an ambulatory pharmacist-led hepatitis C program: A retrospective analysis.
Ortiz J; Rasch M
J Am Pharm Assoc (2003); 2023; 63(1):440-446. PubMed ID: 36272941
[TBL] [Abstract][Full Text] [Related]
14. Optimizing hepatitis C virus treatment through pharmacist interventions: Identification and management of drug-drug interactions.
Langness JA; Nguyen M; Wieland A; Everson GT; Kiser JJ
World J Gastroenterol; 2017 Mar; 23(9):1618-1626. PubMed ID: 28321163
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Advances in HCV Genotype 1 Infection: Insights from the Society of Infectious Diseases Pharmacists.
Deming P; Martin MT; Chan J; Dilworth TJ; El-Lababidi R; Love BL; Mohammad RA; Nguyen A; Spooner LM; Wortman SB
Pharmacotherapy; 2016 Feb; 36(2):203-17. PubMed ID: 26846728
[TBL] [Abstract][Full Text] [Related]
16. Pharmacist-managed telephone clinic review of antidementia medication effectiveness.
Oderda L; Holman C; Nichols B; Rupper R; Bair B; Hoffman M; Hicken B
Consult Pharm; 2011 Apr; 26(4):264-73. PubMed ID: 21486737
[TBL] [Abstract][Full Text] [Related]
17. Pharmacist-led pre-treatment assessment, management and outcomes in a Hepatitis C treatment patient cohort.
Coghlan M; O'Leary A; Melanophy G; Bergin C; Norris S
Int J Clin Pharm; 2019 Oct; 41(5):1227-1238. PubMed ID: 31297695
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of pharmacist care delivery models for hepatitis C clinics.
Naidjate SS; Zullo AR; Dapaah-Afriyie R; Hersey ML; Marshall BDL; Winkler RM; Berard-Collins C
Am J Health Syst Pharm; 2019 May; 76(10):646-653. PubMed ID: 30873537
[TBL] [Abstract][Full Text] [Related]
19. Design of the POINT study: Pharmacotherapy Optimisation through Integration of a Non-dispensing pharmacist in a primary care Team (POINT).
Hazen AC; Sloeserwij VM; Zwart DL; de Bont AA; Bouvy ML; de Gier JJ; de Wit NJ; Leendertse AJ
BMC Fam Pract; 2015 Jul; 16():76. PubMed ID: 26135582
[TBL] [Abstract][Full Text] [Related]
20. Comparative treatment effectiveness of direct acting antiviral regimens for hepatitis C: Data from the Veterans administration.
Fox DS; McGinnis JJ; Tonnu-Mihara IQ; McCombs JS
J Gastroenterol Hepatol; 2017 Jun; 32(6):1136-1142. PubMed ID: 27869323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
